Get the Stockscreener App
3.14
3.09%
-0.10
After Hours:
3.14
Xenetic Biosciences Inc stock is traded at $3.14, with a volume of 2,421.
It is down -3.09% in the last 24 hours and up +10.18% over the past month.
Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing innovative immuno-oncology technologies addressing difficult to treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors.
See More
Previous Close:
$3.24
Open:
$3.12
24h Volume:
2,421
Relative Volume:
0.09
Market Cap:
$4.84M
Revenue:
$2.54M
Net Income/Loss:
$-4.13M
P/E Ratio:
-1.1418
EPS:
-2.75
Net Cash Flow:
$-4.11M
1W Performance:
-2.79%
1M Performance:
+10.18%
6M Performance:
+20.31%
1Y Performance:
-27.31%
1-Day Range:
$3.11
$3.20
1-Week Range:
$3.07
$3.29
52-Week Range:
$2.20
$5.2683
Xenetic Biosciences Inc Stock (XBIO) Company Profile
Name
Xenetic Biosciences Inc
Sector
Industry
Phone
781-778-7720
Address
945 CONCORD ST., FRAMINGHAM, MA
Compare XBIO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XBIO
Xenetic Biosciences Inc
|
3.14 | 5.00M | 2.54M | -4.13M | -4.11M | -2.75 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.64 | 101.35B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.00 | 58.66B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.27 | 59.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
737.56 | 44.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
340.70 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Xenetic Biosciences Inc Stock (XBIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-08-20 | Initiated | Maxim Group | Buy |
Xenetic Biosciences Inc Stock (XBIO) Latest News
Using data models to predict Xenetic Biosciences Inc. stock movementWeekly Market Summary & Free Safe Entry Trade Signal Reports - newser.com
Will Xenetic Biosciences Inc. (3XB0) stock rise with strong economy2025 Trading Volume Trends & Real-Time Volume Surge Alerts - newser.com
Why Xenetic Biosciences Inc. (3XB0) stock fits value portfoliosTrade Exit Summary & Daily Technical Stock Forecast Reports - newser.com
Why analysts recommend Xenetic Biosciences Inc. (3XB0) stockWeekly Investment Report & Weekly Watchlist for Hot Stocks - newser.com
Risk adjusted return profile for Xenetic Biosciences Inc. analyzed2025 Market Overview & Real-Time Buy Signal Notifications - newser.com
Applying Wyckoff theory to Xenetic Biosciences Inc. stockStop Loss & Real-Time Volume Surge Alerts - newser.com
Has Xenetic Biosciences Inc. formed a bullish divergenceMarket Movement Recap & Stepwise Trade Signal Implementation - newser.com
Is Xenetic Biosciences Inc. (3XB0) stock undervalued by metricsQuarterly Risk Review & AI Based Buy and Sell Signals - newser.com
Why Xenetic Biosciences Inc. stock is popular among millennialsEarnings Recap Summary & Daily Stock Trend Watchlist - newser.com
Can Xenetic Biosciences Inc. (3XB0) stock surprise with quarterly resultsRate Hike & Daily Stock Trend Reports - newser.com
Can Xenetic Biosciences Inc. (3XB0) stock stage a strong rebound this quarterRate Hike & Safe Capital Growth Trade Ideas - newser.com
Is Xenetic Biosciences Inc. stock oversold or undervalued2025 Price Action Summary & Verified Technical Signals - newser.com
Earnings visualization tools for Xenetic Biosciences Inc.July 2025 Recap & Safe Capital Investment Plans - newser.com
How Xenetic Biosciences Inc. stock trades before earningsTrade Risk Summary & Real-Time Chart Pattern Alerts - newser.com
What downside risks could hit Xenetic Biosciences Inc. (3XB0) stockJuly 2025 Earnings & Long Hold Capital Preservation Tips - newser.com
Is Xenetic Biosciences Inc a good long term investmentCovered Call Writing & Free Significant Capital Appreciation - earlytimes.in
What analysts say about Xenetic Biosciences Inc stockOptions Trading Strategies & Big Profit Small Capital - earlytimes.in
What drives Xenetic Biosciences Inc stock priceMoving Average Crossovers & Outstanding Portfolio Tips - earlytimes.in
Is Xenetic Biosciences Inc 3XB0 a good long term investmentHigh Yield Income Stocks & Fast Profit Investment Ideas - earlytimes.in
Xenetic Biosciences Inc Stock (XBIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.36%
1.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):